Paroxetine in the first trimester and the prevalence of congenital malformations

@article{Cole2007ParoxetineIT,
  title={Paroxetine in the first trimester and the prevalence of congenital malformations},
  author={J. Cole and S. Ephross and I. Cosmatos and A. Walker},
  journal={Pharmacoepidemiology and Drug Safety},
  year={2007},
  volume={16}
}
To refine a preliminary analysis identifying a possibly increased prevalence of malformations among infants born to women exposed to paroxetine in the first trimester. 
First‐trimester exposure to bupropion and risk of cardiac malformations
Maternal depression, antidepressant prescriptions, and congenital anomaly risk in offspring: a population-based cohort study
Selective serotonin reuptake inhibitor exposure during early pregnancy and the risk of birth defects
  • S. Gentile
  • Medicine
  • Acta psychiatrica Scandinavica
  • 2011
Drug Exposure in Pregnancy and Heart Defects
Topiramate use in pregnancy and the birth prevalence of oral clefts
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 10 REFERENCES
Paroxetine (Paxil) and congenital malformations
Maternal use of selective serotonin re-uptake inhibitors in early pregnancy and infant congenital malformations.
Drugs in pregnancy.
Retinoic acid embryopathy.
Drug Effects on the Fetus and Breast-Fed Infant
  • G. Briggs
  • Medicine
  • Clinical obstetrics and gynecology
  • 2002